Related Articles

Probable cutaneous adverse drug reaction due to a cannabidiol-containing hemp oil product in a dog.

Vet Dermatol. 2020 Jul 31;:

Authors: Simpson AC, Bradley CW, Schissler JR

Abstract
BACKGROUND: Cannabidiol (CBD) in hemp oil has become a widely used product in veterinary medicine. To date, there have been no reports of cutaneous adverse events associated with CBD-containing oil in the veterinary literature.
CLINICAL SUMMARY: A 4-year-old castrated male Labrador retriever presented with pad sloughing and rapidly progressive cutaneous and mucosal ulceration within five days of administering an oral CBD oil product. Histopathological findings in combination with cutaneous signs were consistent with Stevens-Johnson syndrome. All lesions completely resolved after discontinuation of the hemp oil in addition to a 12 day course of cephalexin and prednisone. Given the lack of alternative causes including other medications, an adverse drug event was deemed probable according to the Naranjo algorithm.
CONCLUSIONS AND CLINICAL IMPORTANCE: To the best of the authors’ knowledge, this is the first report of suspected cutaneous adverse drug reaction to a CBD-containing hemp oil product.

PMID: 32735064 [PubMed – as supplied by publisher]


Source: ncbi

Partage le savoir
Categories: Medical

error: Content is protected !!